123 related articles for article (PubMed ID: 37902229)
21. Comparison of the Treatment Outcomes of Photodynamic Therapy and Ingenol Mebutate in Bowen's Disease: A Retrospective Observational Study.
An JH; Shin JU; Kim HJ; Lee HJ; Yoon MS; Kim DH
Ann Dermatol; 2020 Feb; 32(1):47-52. PubMed ID: 33911708
[TBL] [Abstract][Full Text] [Related]
22. Chlorin e6-Mediated Photodynamic Therapy Suppresses P. acnes-Induced Inflammatory Response via NFκB and MAPKs Signaling Pathway.
Wang YY; Ryu AR; Jin S; Jeon YM; Lee MY
PLoS One; 2017; 12(1):e0170599. PubMed ID: 28118375
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
[TBL] [Abstract][Full Text] [Related]
24. PDT-Induced Activation Enhanced by Hormone Response to Treatment.
Domka W; Bartusik-Aebisher D; Przygoda M; Dynarowicz K; Tomik J; Aebisher D
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762219
[TBL] [Abstract][Full Text] [Related]
25. PDT dose dosimetry for pleural photodynamic therapy.
Sharikova AV; Finlay JC; Liang X; Zhu TC
Proc SPIE Int Soc Opt Eng; 2013 Feb; 8568():. PubMed ID: 25999645
[TBL] [Abstract][Full Text] [Related]
26. Single cell transcriptome profiling reveals cutaneous immune microenvironment remodeling by photodynamic therapy in photoaged skin.
Yan Y; Yan G; Cao Z; Wang B; Zeng Q; Shi L; Chang Q; Chen C; Zhang L; Liao C; Jin S; Sun X; Zhang G; Wang P; Wang X
Front Immunol; 2023; 14():1183709. PubMed ID: 37404811
[TBL] [Abstract][Full Text] [Related]
27. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
Chu PL; Shihabuddeen WA; Low KP; Poon DJJ; Ramaswamy B; Liang ZG; Nei WL; Chua KLM; Thong PSP; Soo KC; Yeo ELL; Chua MLK
Photodiagnosis Photodyn Ther; 2019 Sep; 27():367-374. PubMed ID: 31299389
[TBL] [Abstract][Full Text] [Related]
28. Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab.
Ishikawa K; Nishihara H; Ozawa S; Piao CH; Ito Y; Kondo M; Terasaki H
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):273-80. PubMed ID: 21038080
[TBL] [Abstract][Full Text] [Related]
29. Safety of percutaneous dilational tracheostomy in patients ventilated with high positive end-expiratory pressure (PEEP).
Beiderlinden M; Groeben H; Peters J
Intensive Care Med; 2003 Jun; 29(6):944-948. PubMed ID: 12589531
[TBL] [Abstract][Full Text] [Related]
30. Use of alkaline Comet assay to assess DNA repair after m-THPC-PDT.
Rousset N; Keminon E; Eléouet S; Le Néel T; Auget JL; Vonarx V; Carré J; Lajat Y; Patrice T
J Photochem Photobiol B; 2000 Jul; 56(2-3):118-31. PubMed ID: 11079472
[TBL] [Abstract][Full Text] [Related]
31. Photosensitization of a subcutaneous tumour by the natural anthraquinone parietin and blue light.
Mugas ML; Calvo G; Marioni J; Céspedes M; Martinez F; Vanzulli S; Sáenz D; Di Venosa G; Nuñez Montoya S; Casas A
Sci Rep; 2021 Dec; 11(1):23820. PubMed ID: 34893702
[TBL] [Abstract][Full Text] [Related]
32. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
Koukourakis MI; Giatromanolaki A; Skarlatos J; Corti L; Blandamura S; Piazza M; Gatter KC; Harris AL
Cancer Res; 2001 Mar; 61(5):1830-2. PubMed ID: 11280732
[TBL] [Abstract][Full Text] [Related]
34. Mreg Activity in Tumor Response to Photodynamic Therapy and Photodynamic Therapy-Generated Cancer Vaccines.
Korbelik M; Banáth J; Zhang W
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27754452
[TBL] [Abstract][Full Text] [Related]
35. Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons.
Cantisani C; Paolino G; Bottoni U; Calvieri S
J Drugs Dermatol; 2015 Nov; 14(11):1349-53. PubMed ID: 26580886
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical 5-aminolevulinic acid-mediated photodynamic therapy.
Hsu YC; Yang DF; Chiang CP; Lee JW; Tseng MK
Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):310-8. PubMed ID: 23200011
[TBL] [Abstract][Full Text] [Related]
37. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy.
Thong PS; Olivo M; Kho KW; Bhuvaneswari R; Chin WW; Ong KW; Soo KC
J Environ Pathol Toxicol Oncol; 2008; 27(1):35-42. PubMed ID: 18551894
[TBL] [Abstract][Full Text] [Related]
38. Foscan uptake and tissue distribution in relation to photodynamic efficacy.
Cramers P; Ruevekamp M; Oppelaar H; Dalesio O; Baas P; Stewart FA
Br J Cancer; 2003 Jan; 88(2):283-90. PubMed ID: 12610515
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment.
Gu B; Wang B; Li X; Feng Z; Ma C; Gao L; Yu Y; Zhang J; Zheng P; Wang Y; Li H; Zhang T; Chen H
Front Immunol; 2022; 13():1050421. PubMed ID: 36466825
[TBL] [Abstract][Full Text] [Related]
40. A New Optical Method for Online Monitoring of the Light Dose and Dose Profile in Photodynamic Therapy.
Beigzadeh AM; Rashidian Vaziri MR; Ziaie F; Sharif S
Lasers Surg Med; 2020 Sep; 52(7):659-670. PubMed ID: 31777113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
